DELCETRAVIR Trademark

Trademark Overview


On Wednesday, December 22, 2021, a trademark application was filed for DELCETRAVIR with the United States Patent and Trademark Office. The USPTO has given the DELCETRAVIR trademark a serial number of 79331699. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by Esfam Biotech Pty Ltd. The DELCETRAVIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, medicinal and therapeutic medicinal preparations for human and animal use, all for human and animal use for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; pharmaceutical preparations for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; veterinary preparations for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; veterinary pharmaceutical preparations for treatment or prevention of infectious diseases including but not limited to respiratory diseases and disorders
delcetravir

General Information


Serial Number79331699
Word MarkDELCETRAVIR
Filing DateWednesday, December 22, 2021
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7307186
Registration DateTuesday, February 20, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesPharmaceutical, medicinal and therapeutic medicinal preparations for human and animal use, all for human and animal use for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; pharmaceutical preparations for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; veterinary preparations for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; veterinary pharmaceutical preparations for treatment or prevention of infectious diseases including but not limited to respiratory diseases and disorders
Translation of Words in MarkThe wording DELCETRAVIR has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEsfam Biotech Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAU

Party NameEsfam Biotech Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAU

Party NameEsfam Biotech Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAU

Trademark Events


Event DateEvent Description
Tuesday, June 28, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 27, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 1, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, June 22, 2022ASSIGNED TO EXAMINER
Monday, June 27, 2022NON-FINAL ACTION WRITTEN
Thursday, June 30, 2022REFUSAL PROCESSED BY MPU
Thursday, June 30, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 7, 2022ASSIGNED TO EXAMINER
Tuesday, July 19, 2022REFUSAL PROCESSED BY IB
Tuesday, December 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 28, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, July 21, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, October 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 15, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sunday, December 3, 2023NOTIFICATION PROCESSED BY IB
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, July 5, 2024FINAL DISPOSITION PROCESSED
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, July 6, 2024FINAL DISPOSITION NOTICE SENT TO IB
Saturday, July 27, 2024FINAL DECISION TRANSACTION PROCESSED BY IB